Gelium

RMD: Consolidation.

Long
Gelium Updated   
NYSE:RMD   ResMed Inc.
Consolidation could be broken upwards with a minimum target in the region of 280.
Trade active:
Long Call: Buy 1x 15th Oct $250,00 Call @ $3,50
Entry cost: $350,00 (debit)
Maximum risk1: $350,00
Est. return1 at target price: $2 650,00 (757.1%)
Comment:
Trade closed: target reached:

Profit: Long Call: Buy 1x 15th Oct $250,00 Call @ $3,50

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.